Literature DB >> 6276786

Effects of piracetam on the central dopaminergic transmission.

L K Rägo, L H Allikmets, A M Zarkovsky.   

Abstract

The effects of piracetam on dopamine metabolism in rat striatal tissue and on behavioural and biochemical effects of haloperidol were studied. Piracetam in doses 600 mg/kg and 1,000 mg/kg (i.p.) increased the levels of dopamine metabolites (homovanillic acid and 3,4-dihydroxy-phenylacetic acid) but did not influence the content of dopamine in the striatum. Piracetam (1,000 mg/kg) also increased haloperidol-induced catalepsy in rats. These results are discussed in relation to the hypothesis that some behavioural effects of piracetam can be connected with its action on dopaminergic transmission.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6276786     DOI: 10.1007/bf00503309

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  6 in total

1.  The clinical use of piracetam, a new nootropic drug. The treatment of symptoms of senile involution.

Authors:  A J Stegink
Journal:  Arzneimittelforschung       Date:  1972-06

2.  [Piracetam in the modern pharmacotherapy of the Parkinson syndrome].

Authors: 
Journal:  Med Welt       Date:  1978-09-01

3.  Effects of piracetam on brain monoamine metabolism and serum prolactin levels in the rat.

Authors:  H Nybäck; F A Wiesel; P Skett
Journal:  Psychopharmacology (Berl)       Date:  1979-03-28       Impact factor: 4.530

4.  Biological correlates of piracetam clinical effects in psychotic patients.

Authors:  J Kabes; L Erban; L Hanzlicek; V Skondia
Journal:  J Int Med Res       Date:  1979       Impact factor: 1.671

5.  Serotonin--dopamine interactions in the nigrostriatal system.

Authors:  P C Waldmeier; A A Delini-Stula
Journal:  Eur J Pharmacol       Date:  1979-05-15       Impact factor: 4.432

6.  Piracetam in chronic brain failure.

Authors:  S Lloyd-Evans; J C Brocklehurst; M K Palmer
Journal:  Curr Med Res Opin       Date:  1979       Impact factor: 2.580

  6 in total
  3 in total

1.  High versus low-dose piracetam in alcohol organic mental disorder: a placebo controlled study.

Authors:  C Barnas; C Miller; H Ehrmann; P Schett; V Günther; W W Fleischhacker
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Modulating effect of the nootropic drug, piracetam on stress- and subsequent morphine-induced prolactin secretion in male rats.

Authors:  A Matton; S Engelborghs; F Bollengier; E Finné; L Vanhaeist
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

Review 3.  Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders.

Authors:  M W Vernon; E M Sorkin
Journal:  Drugs Aging       Date:  1991-01       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.